OMIG, Abstract 2
Main Page | 2005
Abstracts | <
Previous | Next
of Staph Epidermidis for Keratitis in Rabbits Pre-Treated with Prophylactic
Zymar (Gatifloxacin 0.3%)
Friday and R Snyder, Biomedical Engineering, University of Arizona,
Purpose: Refractive surgeons frequently employ
a postoperative course of 4th-generation flouroquinolones, Zymar®
(gatifloxacin 0.3%) or Vigamox®
(moxifloxacin 0.5%), for keratitis prophylaxis after LASIK. This
study used a rabbit LASIK model to evaluate the comparative efficacy
of a preoperative plus postoperative regimen of gatifioxacin with
a postoperative regimen alone.
Fifty rabbits were divided into two equal groups: control and pretreatment.
The test group was pretreated with one drop gatifloxacin QID the
day preceding surgery and received one more drop before the procedure.
All rabbits received one drop of gatifloxacin post-op and one drop
QID for seven days. Following systemic and topical anesthesia, a
corneal pocket 3.0 x 3.0 mm was dissected at ~120 um depth in the
right eye and inoculated with 2uL of a balanced saline containing
concentrations of 104,105,
cfu's of Staph epidermidis.
The ID50 in the control group (post-op drug only) was found to be
while the test group was 107.
The pretreated group was more resistant to infection, requiring
a 100x greater numbers of bacteria to become infected.
In view of these results, LASIK surgeons may be able to reduce the
risk of bacterial keratitis by implementing gatifloxacin prophylaxis
the day before surgery in addition to a one-week postoperative regimen.
Study supported by an unrestricted grant from Allergan, Inc., RPB
and NIH Grant # NIHT35 HL07479
Main Page | 2005
Abstracts | < Previous
| Next >